North American Rhinology & Allergy Conference

Meeting Program

 

 

Jointly Provided by

American College of Allergy, Asthma & Immunology (ACAAI)

and

North American Rhinology & Allergy Conference (NARAC)

 

Target Audience

  • Practicing allergists and rhinologist
  • Fellows in allergy and rhinology training programs
  • Primary care physicians who care for allergy and rhinology patients
  • Allied health professionals in the field of allergy and rhinology

 

 

Educational Objectives

At the conclusion of this activity, participants should be able to:

●  Recognize the burden of illness related to severe CRS in association with severe asthma.

●  Identify appropriate strategies to determine the diagnosis of chronic rhinosinusitis and its subtypes.

●  Discuss the hypothesized pathophysiologic mechanisms for development of chronic rhinosinusitis.      

●  Discuss the risks and benefits of novel medical and surgical therapeutic modalities for chronic rhinosinusitis in association with severe asthma.

●  Diagnose and treat both upper and lower airway causes of chronic cough including asthma and CRS

●  Develop optimal treatment strategies for moderate to severe allergic rhinitis.

●  Identify, treat and/or refer appropriate patients for skull base surgery

●  Diagnose and treat angioedema of the head and neck

 

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and North American Rhinology & Allergy Conference (NARAC).  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of TBD AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by educational grants from commercial interests. Complete information will be provided to participants prior to the activity.



In compliance with the Americans with Disabilities Act, NARAC requests that any participant in need of special accommodations submit a written request to NARAC well in advance.  Please email Ginny Loiselle at
GinnyLoiselle@NARAConference.org.

                     NARAC 2017 

   

Thursday, February 9

4:30 – 4:55           Allergy immunotherapy:  Advancement of therapy

                                                Michael Blaiss, MD

4:55 – 5:00           Panel Discussion: Q & A

5:00 – 5:25           Evaluation for immunodeficiency in CRS

                                                Anju Peters, MD

5:25 – 5:30           Panel Discussion: Q & A

5:30 – 5:55           The role of antimicrobials in the management of CRS

                                                Simon Carney, MD         

5:55 – 6:00           Panel Discussion: Q & A

6:00 – 6:25           Facial pain: Differential diagnosis, evaluation and management

                                                Rick Chandra, MD

6:25 – 6:30           Panel Discussion: Q & A

6:30 – 6:55           Treating recalcitrant CRS

                                                Robert Kern, MD (moderator), Rick Chandra, MD, 
                                                Noam Cohen, MD, Zach Soler, MD

6:55 – 7:00           Panel Discussion: Q & A

Friday, February 10

7:30 – 7:55           Quality of life in CRS

                                                Timothy Smith, MD

7:55 – 8:00           Panel Discussion: Q & A

8:00 – 8:25           CRS: Definitions, endotypes and pathophysiology

                                                Anju Peters, MD

8:25 – 8:30           Panel Discussion: Q & A

                                How I do it Symposium

8:30 – 8:35           Inferior turbinate reduction

                                                Zach Soler, MD

8:35 – 8:40           Endoscopic septoplasty 

                                                Rick Chandra, MD

8:40 – 8:45           Balloon Sinuplasty

                                                Raj Sindwani, MD

8:45 – 8:50           Endoscopic Lothrop procedure

                                                Simon Carney, MD

8:50 – 9:00           Panel Discussion: Q & A

9:00 – 10:00        PBL: CRScNP and severe asthma

                                                Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD and Michael Blaiss, MD

10:00 – 10:45      Coffee Break

10:45 – 11:00      Post PBL: AERD Update: Epidemiology

                                                Andrew White, MD

11:00 – 11:15        Post PBL: AERD Update: Pathophysiology

                                                Tanya Laidlaw, MD

11:15 – 11:30        Post PBL:  AERD Update: ASA desensitization

                                                Andrew White, MD

11:30 – 11:45       Post PBL:  AERD Update: Optimal timing of sinus surgery

                                                Raj Sindwani, MD

11:45 – 12:00        Panel Discussion: Q & A

12:00 – 12:25        Dermatologic diseases of the nose

                                                Neil Peters, MD

12:25 – 12:30        Panel Discussion: Q & A

12:30 – 1:15          Product Theater

SKULL BASE SURGERY SYMPOSIUM

1:15 – 1:35            Evolution of skull base surgery

                                                Carl Snyderman, MD

1:35 – 1:55            Surgical approaches to the skull base

                                                 Carl Snyderman, MD

1:55 – 2:15            CSF leak repair and skull base reconstruction

                                                 Raj Sindwani, MD

2:15 - 2:35              Hemostasis in sinus and skull base surgery

                                                 Carl Snyderman, MD     

2:35 – 2:45           Panel Discussion: Q & A

Saturday, February 11

7:30 – 7:55           Optimizing post-op FESS care

                                                Ian Witterick, MD

7:55 – 8:00           Panel Discussion: Q & A

8:00 – 8:25           Nasal irrigation and topical drug delivery in the management of CRS

                                                Timothy Smith, MD

8:25 – 8:30           Panel Discussion: Q & A

8:30 – 8:55           Angioedema of the head and neck: Evaluation and management

                                                Russell Settipane, MD   

8:55 – 9:00           Panel Discussion: Q & A

9:00 – 10:00         PBL: Adult with chronic cough  

                                                Ray Davis, MD, Don Bukstein, MD, Russell Settipane, MD 
                        
                                                and Michael Blaiss, MD

10:00 – 10:45      Coffee Break

10:45 – 11:05      Post PBL: upper airway causes of chronic cough

                                                Michael Blaiss, MD

11:05 – 11:20      Post PBL: Lower airway causes of chronic cough

                                                Don Bukstein, MD 

11:20 – 11:30      Panel Discussion: Q & A

11:30 – 11:55      The role of office procedures in the management of sinonasal disease

        Raj Sindwani, MD (moderator), Ian Witterick, MD, Robert Kern, MD,      

        David Conley, MD

11:55 – 12:00      Panel Discussion: Q & A

12:00 – 12:45      Product Theater

SYMPOSIUM:  Severe asthma and CRScNP - Burden of illness in Puerto Rico

12:45 – 1:10        Severe asthma in Puerto Rico: Burden of illness

                                                Cristina Ramos, MD

1:10 – 1:35           Optimizing medical management of severe asthma

                                                Rey Panettieri, MD

1:35 – 2:05           Perioperative use of steroids in endoscopic sinus surgery

                                                Jose Busquets, MD and Gustavo  Almodóvar-Mercado, MD

2:05 – 2:30           Management of severe CRS: What does the future hold?

                                                Tanya Laidlaw, MD

2:30 – 2:45           Panel Discussion: Q & A

 

  

 

 

Website Builder